Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | AKT2 | P31751 | 2/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PRKACA | P17612 | 1/20 | 0.46 |
| ▸ | PRKACG | P22612 | 1/20 | 0.46 |
| ▸ | PRKACB | P22694 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | PI4KA | P42356 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13651702 | 0.85 | CYP1A2 (0.48) | CYP1A2TSHRCYP2C19AKT1AKT2 | |
| SCHEMBL14391654 | 0.81 | CYP1A2 (0.44) | CYP1A2TSHRCYP2C19MEN1ALDH1A1 | |
| SCHEMBL4063885 | 0.81 | CYP1A2 (0.56) | CYP1A2TSHRCYP2C19AKT1AKT2 | |
| SCHEMBL4134543 | 0.76 | CYP2C19 (0.57) | CYP1A2TSHRCYP2C19MEN1ALDH1A1 | |
| SCHEMBL4068137 | 0.74 | CYP1A2 (0.49) | CYP1A2TSHRCYP2C19MEN1ALDH1A1 | |
| SCHEMBL4137893 | 0.73 | CYP1A2 (0.54) | CYP1A2TSHRCYP2C19AKT2MEN1 | |
| SCHEMBL4063305 | 0.72 | CYP1A2 (0.53) | CYP1A2TSHRCYP2C19MEN1ALDH1A1 | |
| SCHEMBL4122030 | 0.72 | NPC1 (0.60) | CYP1A2TSHRCYP2C19AKT2PRKACA | |
| SCHEMBL4070092 | 0.72 | NPC1 (0.54) | CYP1A2TSHRCYP2C19AKT2MEN1 | |
| SCHEMBL22111670 | 0.72 | CYP2C19 (0.52) | CYP1A2TSHRCYP2C19CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090253718-A1 | Pharmaceutical Compounds | ASTEX THERAPEUTICS LIMITED (GB) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253718-A1 | Pharmaceutical Compounds | GRK3, CNKSR1, CSNK1G3 | CYP1A2 1220/4885TSHR 165/4885CYP2C19 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.